Postoperative Acetaminophen Use and Acute Kidney Injury in Abdominal Surgery: A MIMIC-IV Analysis

Postoperative renal impairment remains a frequent complication following major abdominal procedures. Medical professionals often rely on various analgesics to manage pain during recovery periods. While nonsteroidal anti-inflammatory drugs are common, their potential for nephrotoxicity limits their utility. That uncertainty drove interest in safer alternatives for pain control. No prior work had resolved the specific impact of acetaminophen on renal outcomes in this surgical population. This gap motivated an examination of large-scale electronic health records. Previous investigations primarily focused on other medication classes rather than this specific analgesic. Understanding these associations is necessary to improve patient safety protocols after complex operations.

This study aims to investigate the association between postoperative acetaminophen use and the incidence of acute kidney injury in abdominal surgery patients. Many clinicians remain uncertain about the renal safety profile of this common analgesic in surgical settings. While nonsteroidal anti-inflammatory drugs are frequently avoided due to kidney risks, the role of acetaminophen is not fully understood. This research seeks to clarify whether this medication provides a protective effect for patients recovering from major operations. The investigators specifically analyze data from a large cohort to determine if timing of administration influences outcomes. By examining various subgroups, the authors intend to identify which patients benefit most from this pain management strategy. This work addresses the need for evidence-based alternatives to traditional analgesics that may cause renal harm. The findings are intended to inform clinical decision-making regarding postoperative care protocols.

The investigators conducted a retrospective cohort study using the MIMIC-IV database. This approach allowed for the evaluation of 8,696 individuals who received surgical care. Researchers assessed the relationship between medication delivery and renal outcomes. They utilized multivariable logistic regression to control for various clinical factors. Cox proportional hazards models helped determine the risk of injury over time. The team focused on drug administration within the first two days after the procedure. They also performed subgroup evaluations based on gender, anemia, and sodium levels. This design enabled a comprehensive assessment of the protective associations across diverse patient profiles.

Acetaminophen use within 48 hours postsurgery was linked to a 40% reduction in acute kidney injury risk. The calculated odds ratio for this association was 0.60 with a 95% confidence interval of 0.54 to 0.67. Hazard ratio analysis yielded a value of 0.57 within a 95% confidence interval of 0.53 to 0.62. Females experienced a stronger protective effect with a hazard ratio of 0.51 compared to 0.62 for males. Patients with severe anemia showed a hazard ratio of 0.44. Those with hyponatremia demonstrated a hazard ratio of 0.47. Individuals undergoing open surgery exhibited a hazard ratio of 0.50. Time-dependent analysis showed that delayed administration between 18 and 48 hours provided the most significant protection.

The authors propose that acetaminophen administration correlates with lower renal injury rates after abdominal surgery. These results indicate a potential benefit compared to traditional non-steroidal anti-inflammatory agents. Researchers highlight that the protective association appears stronger in specific patient demographics. Females and individuals with severe anemia or hyponatremia showed more pronounced risk reductions. The data suggest that timing of medication delivery influences the magnitude of the observed effect. Delayed administration within the initial two-day window provided superior outcomes in this cohort. These observations support the consideration of this drug as a preferred pain management strategy. Prospective trials are required to refine optimal dosing schedules and clinical timing.